Formulary Acceptance Rate is a critical KPI that measures the percentage of drugs accepted onto a formulary, impacting both market access and revenue growth.
A higher acceptance rate can lead to improved financial health and operational efficiency, while a lower rate may indicate barriers in negotiations or market positioning.
This metric serves as a leading indicator of a company's ability to penetrate markets and achieve strategic alignment with healthcare providers.
By tracking this KPI, organizations can better forecast sales and optimize resource allocation, ultimately driving better business outcomes.
High formulary acceptance rates signal effective negotiation strategies and strong relationships with payers. Conversely, low rates may indicate challenges in product differentiation or pricing strategies. Ideal targets typically exceed 80% acceptance to ensure robust market presence.
Many organizations overlook the importance of continuous monitoring of formulary acceptance rates, leading to missed opportunities for improvement.
Enhancing formulary acceptance rates requires a proactive approach to stakeholder engagement and value communication.
A leading biopharmaceutical company faced challenges with its formulary acceptance rate, which hovered around 65%. This low rate was impacting its ability to achieve revenue targets and expand market share. The company initiated a comprehensive review of its formulary submission process, focusing on enhancing its value proposition and stakeholder engagement.
The team established a cross-functional task force to analyze payer feedback and competitor strategies. They identified key areas for improvement, including clearer messaging around the clinical benefits and cost-effectiveness of their products. Additionally, they engaged with healthcare providers to understand their needs and concerns better, ensuring that their submissions were aligned with market expectations.
Within 12 months, the company improved its formulary acceptance rate to 82%. This increase led to a significant boost in revenue, allowing the organization to reinvest in research and development. The success of this initiative demonstrated the value of a data-driven approach and proactive stakeholder engagement in achieving strategic business outcomes.
This KPI is associated with the following categories and industries in our KPI database:
KPI Depot takes you from KPI intelligence to finished deliverable. Consultants, strategy teams, FP&A leaders, and analytics teams use it to answer the two hardest questions in performance management, what to measure and what the target should be, and then to produce the scorecard itself.
The difference is intelligence, not just data. Anyone can list metrics. Every KPI in KPI Depot carries 13 practical attributes, from formula and measurement approach to diagnostic questions, risk warnings, and Balanced Scorecard perspective, across 15 corporate functions and 153 industries. And every target you set is grounded in our database of 34,304 source-attributed benchmarks, each detailing metric value, company size, time period, industry, geography, sample size, and source. Benchmark data at this scale is otherwise the domain of research services costing thousands to hundreds of thousands of dollars per year.
When your metrics are selected, KPI Depot finishes the job: export an interactive Strategy Map, a Balanced Scorecard with formulas and tracking columns, or a CSV KPI pack, and go from research to working deliverable in hours instead of weeks.
Formerly the Flevy KPI Library, KPI Depot is trusted by teams at organizations including Accenture, EY, IBM, PepsiCo, Samsung, and Vodafone.
Got a question? Email us at [email protected].
Key factors include the clinical efficacy of the drug, pricing strategies, and the strength of relationships with payers. Understanding these elements can help organizations tailor their approaches for better outcomes.
Regular reviews, ideally quarterly, allow organizations to stay agile and responsive to market changes. Frequent assessments can highlight trends and inform strategic adjustments.
While immediate improvements are challenging, targeted strategies can yield results over time. Focused efforts on stakeholder engagement and value communication can gradually enhance acceptance rates.
No, while it's important, organizations should also monitor related metrics such as market share and sales growth. A holistic view provides better insights into overall performance.
Higher acceptance rates typically lead to increased market access, driving revenue growth. Conversely, low rates can limit sales potential and market penetration.
Data analytics provide insights into trends, competitor strategies, and payer preferences. Leveraging this information can enhance decision-making and improve formulary outcomes.
Each KPI in our knowledge base includes 13 attributes.
A clear explanation of what the KPI measures
The typical business insights we expect to gain through the tracking of this KPI
An outline of the approach or process followed to measure this KPI
The standard formula organizations use to calculate this KPI
Insights into how the KPI tends to evolve over time and what trends could indicate positive or negative performance shifts
Questions to ask to better understand your current position is for the KPI and how it can improve
Practical, actionable tips for improving the KPI, which might involve operational changes, strategic shifts, or tactical actions
Recommended charts or graphs that best represent the trends and patterns around the KPI for more effective reporting and decision-making
Potential risks or warnings signs that could indicate underlying issues that require immediate attention
Suggested tools, technologies, and software that can help in tracking and analyzing the KPI more effectively
How the KPI can be integrated with other business systems and processes for holistic strategic performance management
Explanation of how changes in the KPI can impact other KPIs and what kind of changes can be expected
NEW Mapping to a Balanced Scorecard perspective (financial, customer, internal process, learning & growth)